4.6 Article

The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Direct oral anticoagulant use and risk of severe COVID-19

B. Flam et al.

Summary: The study found that ongoing DOAC use was not associated with reducing the risk of severe COVID-19, suggesting that early outpatient DOAC initiation would not modify prognosis.

JOURNAL OF INTERNAL MEDICINE (2021)

Article Medicine, General & Internal

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19 The ACTIV-4B Randomized Clinical Trial

Jean M. Connors et al.

Summary: This study aimed to assess the impact of anticoagulant or antiplatelet therapy on symptomatic clinically stable outpatients with COVID-19. The results showed that treatment with aspirin or apixaban compared with placebo did not reduce the rate of a composite clinical outcome, and the study was terminated early due to a lower than anticipated event rate.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Cardiac & Cardiovascular Systems

Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study

Richard Chocron et al.

Summary: The study found that COVID-19 patients receiving anticoagulation therapy before hospitalization had a better prognosis, while those starting anticoagulation therapy during hospitalization were not associated with any outcomes. Early introduction of anticoagulation therapy can help prevent COVID-19-associated coagulopathy and endotheliopathy, leading to a better prognosis for patients.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Medicine, General & Internal

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial

Parham Sadeghipour et al.

Summary: This study compared the effect of intermediate-dose and standard prophylactic anticoagulation on a composite outcome among COVID-19 patients admitted to the ICU. The results showed no significant difference between the two groups in terms of thrombotic events, ECMO therapy, or mortality within 30 days. The study does not recommend routine use of intermediate-dose prophylactic anticoagulation in unselected ICU patients with COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

Renato D. Lopes et al.

Summary: In hospitalized COVID-19 patients with elevated D-dimer concentration, in-hospital therapeutic anticoagulation with rivaroxaban or enoxaparin followed by rivaroxaban to day 30 did not improve clinical outcomes and increased bleeding compared with prophylactic anticoagulation. Therapeutic-dose rivaroxaban and other direct oral anticoagulants should be avoided in these patients without an evidence-based indication for oral anticoagulation.

LANCET (2021)

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

Patrick R. Lawler et al.

Summary: This study showed that therapeutic-dose anticoagulation with heparin in non-critically ill patients with Covid-19 increased the likelihood of survival to hospital discharge and reduced the need for cardiovascular or respiratory organ support compared to usual-care thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Ewan C. Goligher et al.

Summary: In critically ill patients with Covid-19, initial therapeutic-dose anticoagulation did not result in improved survival rates or fewer days requiring cardiovascular or respiratory organ support compared to usual-care pharmacologic thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients

Sameh M. Hozayen et al.

Summary: Anticoagulation therapy may be associated with the risk of hospitalization and mortality in COVID-19 patients. Outpatients on anticoagulation therapy at the time of diagnosis experienced a reduced risk of hospitalization, but it did not affect mortality. Inpatients who were not on anticoagulation had an increased risk of mortality.

ECLINICALMEDICINE (2021)

Article Health Care Sciences & Services

Predicting COVID-19 mortality with electronic medical records

Hossein Estiri et al.

Summary: This study utilizes past medical information collected in EHRs to predict death after COVID-19 infection and identifies age, pneumonia history, diabetes with complications, cancer, and pulmonary diseases as important risk factors for mortality prediction.

NPJ DIGITAL MEDICINE (2021)

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Hematology

COVID-19 and its implications for thrombosis and anticoagulation

Jean M. Connors et al.

Editorial Material Cardiac & Cardiovascular Systems

Coronaviruses and the cardiovascular system: acute and long-term implications

Tian-Yuan Xiong et al.

EUROPEAN HEART JOURNAL (2020)

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Cardiac & Cardiovascular Systems

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow

Behnood Bikdeli et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Geriatrics & Gerontology

Coronavirus Disease 2019 in Geriatrics and Long-Term Care: The ABCDs of COVID-19

Heather D'Adamo et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2020)

Review Cardiac & Cardiovascular Systems

The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications

James D. McFadyen et al.

CIRCULATION RESEARCH (2020)

Letter Hematology

COVID-19 mortality in patients on anticoagulants and antiplatelet agents

Helena Sivaloganathan et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Article Medicine, General & Internal

For-profit long-term care homes and the risk of COVID-19 outbreaks and resident deaths

Nathan M. Stall et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)

Article Medicine, General & Internal

Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy

Giacomo Grasselli et al.

JAMA INTERNAL MEDICINE (2020)

Letter Medicine, General & Internal

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System

Seda Bilaloglu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Ethics

COVID-19-related deaths in long-term care: The moral failure to care and prepare

Somayeh Faghanipour et al.

NURSING ETHICS (2020)

Editorial Material Medicine, General & Internal

Anticoagulation in Hospitalized Patients with Covid-19

Jehan F. Chowdhury et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Thromboembolic Complications in Patients With COVID-19

Gregory Piazza et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Editorial Material Cardiac & Cardiovascular Systems

Coronaviruses and the cardiovascular system: acute and long-term implications

Tian-Yuan Xiong et al.

EUROPEAN HEART JOURNAL (2020)

Article Health Care Sciences & Services

Identifying diabetes cases from administrative data: a population-based validation study

Lorraine L. Lipscomb et al.

BMC HEALTH SERVICES RESEARCH (2018)

Article Public, Environmental & Occupational Health

Matching Weights to Simultaneously Compare Three Treatment Groups Comparison to Three-way Matching

Kazuki Yoshida et al.

EPIDEMIOLOGY (2017)

Editorial Material Cardiac & Cardiovascular Systems

Identifying Patients With Atrial Fibrillation in Administrative Data

Karen Tu et al.

CANADIAN JOURNAL OF CARDIOLOGY (2016)

Article Clinical Neurology

Accuracy of Administrative Data for the Coding of Acute Stroke and TIAs

Ruth Hall et al.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2016)

Article Cardiac & Cardiovascular Systems

Introduction to the Analysis of Survival Data in the Presence of Competing Risks

Peter C. Austin et al.

CIRCULATION (2016)

Article Medicine, General & Internal

Rates of hemorrhage during warfarin therapy for atrial fibrillation

Tara Gomes et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)

Article Mathematical & Computational Biology

A Weighting Analogue to Pair Matching in Propensity Score Analysis

Liang Li et al.

INTERNATIONAL JOURNAL OF BIOSTATISTICS (2013)

Article Health Care Sciences & Services

ICD-10 adaptations of the Ontario acute myocardial infarction mortality prediction rules performed as well as the original versions

Marian J. Vermeulen et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)

Article Health Care Sciences & Services

Administrative data accurately identified intensive care unit admissions in Ontario

Damon C. Scales et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)